215 related articles for article (PubMed ID: 18716676)
1. Complex ecological dynamics and eradicability of the vector borne macroparasitic disease, lymphatic filariasis.
Gambhir M; Michael E
PLoS One; 2008 Aug; 3(8):e2874. PubMed ID: 18716676
[TBL] [Abstract][Full Text] [Related]
2. Geographic and ecologic heterogeneity in elimination thresholds for the major vector-borne helminthic disease, lymphatic filariasis.
Gambhir M; Bockarie M; Tisch D; Kazura J; Remais J; Spear R; Michael E
BMC Biol; 2010 Mar; 8():22. PubMed ID: 20236528
[TBL] [Abstract][Full Text] [Related]
3. Vector transmission heterogeneity and the population dynamics and control of lymphatic filariasis.
Michael E; Gambhir M
Adv Exp Med Biol; 2010; 673():13-31. PubMed ID: 20632527
[TBL] [Abstract][Full Text] [Related]
4. Potential factors influencing lymphatic filariasis transmission in "hotspot" and "control" areas in Ghana: the importance of vectors.
Pi-Bansa S; Osei JHN; Frempong KK; Elhassan E; Akuoko OK; Agyemang D; Ahorlu C; Appawu MA; Koudou BG; Wilson MD; de Souza DK; Dadzie SK; Utzinger J; Boakye DA
Infect Dis Poverty; 2019 Feb; 8(1):9. PubMed ID: 30717788
[TBL] [Abstract][Full Text] [Related]
5. Heterogeneous dynamics, robustness/fragility trade-offs, and the eradication of the macroparasitic disease, lymphatic filariasis.
Michael E; Singh BK
BMC Med; 2016 Jan; 14():14. PubMed ID: 26822124
[TBL] [Abstract][Full Text] [Related]
6. Continental-scale, data-driven predictive assessment of eliminating the vector-borne disease, lymphatic filariasis, in sub-Saharan Africa by 2020.
Michael E; Singh BK; Mayala BK; Smith ME; Hampton S; Nabrzyski J
BMC Med; 2017 Sep; 15(1):176. PubMed ID: 28950862
[TBL] [Abstract][Full Text] [Related]
7. Bayesian calibration of simulation models for supporting management of the elimination of the macroparasitic disease, Lymphatic Filariasis.
Singh BK; Michael E
Parasit Vectors; 2015 Oct; 8():522. PubMed ID: 26490350
[TBL] [Abstract][Full Text] [Related]
8. Transmission models and management of lymphatic filariasis elimination.
Michael E; Gambhir M
Adv Exp Med Biol; 2010; 673():157-71. PubMed ID: 20632536
[TBL] [Abstract][Full Text] [Related]
9. Determinants of the eradicability of filarial infections: a conceptual approach.
Duerr HP; Dietz K; Eichner M
Trends Parasitol; 2005 Feb; 21(2):88-96. PubMed ID: 15664532
[TBL] [Abstract][Full Text] [Related]
10. Global eradication of lymphatic filariasis: the value of chronic disease control in parasite elimination programmes.
Michael E; Malecela MN; Zervos M; Kazura JW
PLoS One; 2008 Aug; 3(8):e2936. PubMed ID: 18698350
[TBL] [Abstract][Full Text] [Related]
11. Lymphatic filariasis in Papua New Guinea: prospects for elimination.
Bockarie MJ; Kazura JW
Med Microbiol Immunol; 2003 Feb; 192(1):9-14. PubMed ID: 12592558
[TBL] [Abstract][Full Text] [Related]
12. Simulating a Transmission Assessment Survey: An evaluation of current methods used in determining the elimination of the neglected tropical disease, Lymphatic Filariasis.
Weiss PS; Michael E; Richards FO
Int J Infect Dis; 2021 Jan; 102():422-428. PubMed ID: 33130207
[TBL] [Abstract][Full Text] [Related]
13. Mathematical models and lymphatic filariasis control: endpoints and optimal interventions.
Michael E; Malecela-Lazaro MN; Kabali C; Snow LC; Kazura JW
Trends Parasitol; 2006 May; 22(5):226-33. PubMed ID: 16564745
[TBL] [Abstract][Full Text] [Related]
14. The impact of six rounds of single-dose mass administration of diethylcarbamazine or ivermectin on the transmission of Wuchereria bancrofti by Culex quinquefasciatus and its implications for lymphatic filariasis elimination programmes.
Ramaiah KD; Das PK; Vanamail P; Pani SP
Trop Med Int Health; 2003 Dec; 8(12):1082-92. PubMed ID: 14641843
[TBL] [Abstract][Full Text] [Related]
15. How effective is integrated vector management against malaria and lymphatic filariasis where the diseases are transmitted by the same vector?
Stone CM; Lindsay SW; Chitnis N
PLoS Negl Trop Dis; 2014 Dec; 8(12):e3393. PubMed ID: 25501002
[TBL] [Abstract][Full Text] [Related]
16. Current practices in the management of lymphatic filariasis.
Bockarie MJ; Taylor MJ; Gyapong JO
Expert Rev Anti Infect Ther; 2009 Jun; 7(5):595-605. PubMed ID: 19485799
[TBL] [Abstract][Full Text] [Related]
17. Transmission dynamics of lymphatic filariasis: density-dependence in the uptake of Wuchereria bancrofti microfilariae by vector mosquitoes.
Snow LC; Michael E
Med Vet Entomol; 2002 Dec; 16(4):409-23. PubMed ID: 12510894
[TBL] [Abstract][Full Text] [Related]
18. Evaluating elimination thresholds and stopping criteria for interventions against the vector-borne macroparasitic disease, lymphatic filariasis, using mathematical modelling.
Sharma S; Smith ME; Bilal S; Michael E
Commun Biol; 2023 Feb; 6(1):225. PubMed ID: 36849730
[TBL] [Abstract][Full Text] [Related]
19. Sequential modelling of the effects of mass drug treatments on anopheline-mediated lymphatic filariasis infection in Papua New Guinea.
Singh BK; Bockarie MJ; Gambhir M; Siba PM; Tisch DJ; Kazura J; Michael E
PLoS One; 2013; 8(6):e67004. PubMed ID: 23826185
[TBL] [Abstract][Full Text] [Related]
20. Mathematical modelling and the control of lymphatic filariasis.
Michael E; Malecela-Lazaro MN; Simonsen PE; Pedersen EM; Barker G; Kumar A; Kazura JW
Lancet Infect Dis; 2004 Apr; 4(4):223-34. PubMed ID: 15050941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
